PubMed

Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects.

Haffner SM, Tuttle KR, Rainwater DL.

Diabetes Care. 1991 Apr;14(4):302-7.PMID: 1829405 [PubMed - indexed for MEDLINE]Related articles

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.

Haffner SM, Tuttle KR, Rainwater DL.

Metabolism. 1992 Feb;41(2):116-20.PMID: 1531244 [PubMed - indexed for MEDLINE]Related articles

Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group.

[No authors listed]

Diabetes Care. 1992 Jul;15(7):886-94.PMID: 1516509 [PubMed - indexed for MEDLINE]Related articles

Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.

Pérez A, Carreras G, Caixàs A, Castellví A, Caballero A, Bonet R, Ordóñez-Llanos J, de Leiva A.

Diabetes Care. 1998 Sep;21(9):1517-20.PMID: 9727901 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.

Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY.

Diabetes Care. 1995 Aug;18(8):1191-4.PMID: 7587858 [PubMed - indexed for MEDLINE]Related articles

Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.

Guerci B, Igau B, Ziegler O, Crea T, Fruchart JC, Drouin P, Fievet C.

Metabolism. 1996 Apr;45(4):430-4.PMID: 8609827 [PubMed - indexed for MEDLINE]Related articles

Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?

Alagözlü H, Gültekin F, Candan F.

Nutr Metab Cardiovasc Dis. 2000 Aug;10(4):204-8.PMID: 11079258 [PubMed - indexed for MEDLINE]Related articles

Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus.

Haffner SM, Frangos M, Williamson J, Santiago J, Valdez R, Aldrete G, Mykkänen L, Gruber KK, Rainwater DL.

Chem Phys Lipids. 1994 Jan;67-68:223-31.PMID: 8187217 [PubMed - indexed for MEDLINE]Related articles

Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.

Kikuchi T, Onuma T, Shimura M, Tsutsui M, Boku A, Matsui J, Takebe K.

Diabetes Care. 1994 Sep;17(9):1059-61.PMID: 7988307 [PubMed - indexed for MEDLINE]Related articles

Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.

Rudberg S, Persson B.

Diabetes Care. 1995 Jul;18(7):933-9.PMID: 7555552 [PubMed - indexed for MEDLINE]Related articles

The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM.

Austin A, Warty V, Janosky J, Arslanian S.

Diabetes Care. 1993 Feb;16(2):421-5.PMID: 8432211 [PubMed - indexed for MEDLINE]Related articles

Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism.

Petersen KR, Skouby SO, Vedel P, Haaber AB.

Diabetes Care. 1995 Jun;18(6):800-6.PMID: 7555506 [PubMed - indexed for MEDLINE]Related articles

Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, Brunzell JD.

Diabetes. 1995 Oct;44(10):1218-26.PMID: 7556961 [PubMed - indexed for MEDLINE]Related articles

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein(a) in diabetic patients with and without chronic renal failure.

Guillausseau PJ, Peynet J, Chanson P, Legrand A, Altman JJ, Poupon J, N'Guyen M, Rousselet F, Lubetzki J.

Diabetes Care. 1992 Aug;15(8):976-9.PMID: 1387074 [PubMed - indexed for MEDLINE]Related articles

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A.

Arch Intern Med. 2000 Oct 9;160(18):2756-62.PMID: 11025785 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum lipoprotein(a) in patients with diabetes mellitus.

Heller FR, Jamart J, Honore P, Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC, Buysschaert M.

Diabetes Care. 1993 May;16(5):819-23.PMID: 8495624 [PubMed - indexed for MEDLINE]Related articles

Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

Patti L, Di Marino L, Maffettone A, Romano G, Annuzzi G, Riccardi G, Rivellese AA.

Diabetologia. 1995 Dec;38(12):1419-24.PMID: 8786015 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

Manzato E, Zambon A, Zambon S, Nosadini R, Doria A, Marin R, Crepaldi G.

Acta Diabetol. 1993;30(1):11-6.PMID: 8329725 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein(a) levels in black and white children and adolescents with IDDM.

Levitsky LL, Scanu AM, Gould SH.

Diabetes Care. 1991 Apr;14(4):283-7.PMID: 1829404 [PubMed - indexed for MEDLINE]Related articles